Willis Investment Counsel Ampio Pharmaceuticals, Inc. Transaction History

Willis Investment Counsel

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$0.16 - $0.47 $332,134 - $975,644	-2,075,840 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.42 - $0.62 $44,520 - $65,720	-106,000 Reduced 4.86%	2,075,840 $976,000
Q4 2021 Feb 14, 2022	BUY	$0.56 - $1.71 $84,000 - $256,500	150,000 Added 7.38%	2,181,840 $1.24 Million
Q3 2021 Nov 17, 2021	SELL	$1.21 - $1.8 $185,130 - $275,400	-153,000 Reduced 7.0%	2,031,840 $3.37 Million
Q2 2021 Aug 13, 2021	BUY	$1.56 - $1.98 $34,320 - $43,560	22,000 Added 1.02%	2,184,840 $3.65 Million
Q1 2021 May 17, 2021	BUY	$1.36 - $2.49 $1.29 Million - $2.36 Million	949,787 Added 78.3%	2,162,840 $3.66 Million
Q4 2020 Feb 11, 2021	BUY	$0.75 - $2.76 $909,789 - $3.35 Million	1,213,053 New	1,213,053 $1.93 Million

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Willis Investment Counsel with notifications on news.